Cargando…

Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq

Lingguizhugan decoction, a classic traditional Chinese medicine formula, has been used to treat non-alcoholic fatty liver disease (NAFLD), however, the underlying mechanisms remains unclear. In the present study, we compared the phenotype of the normal rats (fed with chow diet), high-fat-diet (HFD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Mingzhe, Hao, Shijun, Liu, Tao, Yang, Lili, Zheng, Peiyong, Zhang, Li, Ji, Guang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669915/ https://www.ncbi.nlm.nih.gov/pubmed/29137289 http://dx.doi.org/10.18632/oncotarget.19734

Ejemplares similares

Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion
por: Yang, Lili, et al.
Publicado: (2017)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: Study protocol for a multicenter randomized controlled trial
por: Xu, Jingjuan, et al.
Publicado: (2020)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Erratum to “Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease”
por: Yang, Fuyuan, et al.
Publicado: (2022)

Lingguizhugan Decoction Targets Intestinal Microbiota and Metabolites to Reduce Insulin Resistance in High-Fat Diet Rats
por: Ning, Ying, et al.
Publicado: (2022)

Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota
por: Liu, Meng-Ting, et al.
Publicado: (2019)

Chinese Medicine Formula Lingguizhugan Decoction Improves Beta-Oxidation and Metabolism of Fatty Acid in High-Fat-Diet-Induced Rat Model of Fatty Liver Disease
por: Liu, Tao, et al.
Publicado: (2013)

Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages
por: Cao, Lin, et al.
Publicado: (2022)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

TrancriptomeReconstructoR: data-driven annotation of complex transcriptomes
por: Ivanov, Maxim, et al.
Publicado: (2021)

Protective effects of Lingguizhugan decoction on amyloid-beta peptide (25-35)-induced cell injury: Anti-inflammatory effects☆
por: Xi, Feifei, et al.
Publicado: (2012)

Novel insights into the insect trancriptome response to a natural DNA virus
por: McTaggart, Seanna J, et al.
Publicado: (2015)

Modified lingguizhugan decoction incorporated with dietary restriction and exercise ameliorates hyperglycemia, hyperlipidemia and hypertension in a rat model of the metabolic syndrome
por: Yao, Limei, et al.
Publicado: (2017)

Phytochemical Analysis Using UPLC-MS/MS Combined with Network Pharmacology Methods to Explore the Biomarkers for the Quality Control of Lingguizhugan Decoction
por: Li, Baolin, et al.
Publicado: (2021)

Publisher Correction to: TrancriptomeReconstructoR: data‑driven annotation of complex transcriptomes
por: Ivanov, Maxim, et al.
Publicado: (2021)

Application of an Integrative Computational Framework in Trancriptomic Data of Atherosclerotic Mice Suggests Numerous Molecular Players
por: Papadodima, Olga, et al.
Publicado: (2012)

Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation in vitro and in vivo
por: Yin, Guoliang, et al.
Publicado: (2022)

A Study on the Therapeutic Efficacy of San Zi Yang Qin Decoction for Non-Alcoholic Fatty Liver Disease and the Underlying Mechanism Based on Network Pharmacology
por: Li, Yiping, et al.
Publicado: (2021)

Proteo-Trancriptomic Analyses Reveal a Large Expansion of Metalloprotease-Like Proteins in Atypical Venom Vesicles of the Wasp Meteorus pulchricornis (Braconidae)
por: Gatti, Jean-Luc, et al.
Publicado: (2021)

The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules
por: Dang, Yanqi, et al.
Publicado: (2019)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Systems pharmacology-based exploration reveals mechanisms of anti-steatotic effects of Jiang Zhi Granule on non-alcoholic fatty liver disease
por: Zheng, Yiyuan, et al.
Publicado: (2018)

Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
por: Yan, Bao-Fei, et al.
Publicado: (2023)

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
por: Zhao, Tian, et al.
Publicado: (2021)

Multi-Omics Integration Analysis Identifies Lipid Disorder of a Non-Alcoholic Fatty Liver Disease (NAFLD) Mouse Model Improved by Zexie–Baizhu Decoction
por: Cao, Yuhan, et al.
Publicado: (2022)

Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease
por: Hu, Qichao, et al.
Publicado: (2020)

Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease
por: Korish, Aida A, et al.
Publicado: (2013)

A study on the altered glycemic and lipid parameters and prevalence of insulin resistance in nonalcoholic fatty liver disease
por: Suresh, Sangeetha, et al.
Publicado: (2018)

Integrated analysis of hepatic mRNA and miRNA profiles identified molecular networks and potential biomarkers of NAFLD
por: Zhu, Mingzhe, et al.
Publicado: (2018)

RNA-Seq of Kaposi’s sarcoma reveals alterations in glucose and lipid metabolism
por: Tso, For Yue, et al.
Publicado: (2018)

Lipid droplet dynamics in alcoholic fatty liver disease
por: Schulze, Ryan J., et al.
Publicado: (2019)

Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease
por: Cao, Jun, et al.
Publicado: (2022)

Insulin resistance and lipid alterations in subclinical hypothyroidism
por: Sridevi, Atluri, et al.
Publicado: (2012)

Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study
por: Zhang, Weiwei, et al.
Publicado: (2017)

Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease
por: Chao, Hsu-Wen, et al.
Publicado: (2019)

Sex differences in the association between adipose insulin resistance and non-alcoholic fatty liver disease in Chinese adults
por: Wei, Ying, et al.
Publicado: (2023)

Transcriptomics Analysis of Candida albicans Treated with Huanglian Jiedu Decoction Using RNA-seq
por: Yang, Qianqian, et al.
Publicado: (2016)

Role of thiazolidinediones, insulin sensitizers, in non‐alcoholic fatty liver disease
por: Chang, Eugene, et al.
Publicado: (2013)

Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
por: Yki-Järvinen, Hannele
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0nqeor9ktjchjb7os1d3rb9fv9